Rank | 1ry LOINC Code | UMLS Lab. Procedure | UMLS Definition | nTotal |
---|---|---|---|---|
1 | 59,826–8 | C3525719 | Measurement of creatinine in blood | 1817 |
2 | 7918–6 | C3714540 | HIV Antibody Measurement | 1670 |
3 | 13,955–0 | C0201487 | Hepatitis C antibody measurement | 1595 |
4 | 76,625–3 | C0201836 | Alanine aminotransferase measurement | 1464 |
5 | 63,557–3 | C0201477 | Hepatitis B surface antigen measurement | 1462 |
6 | 2106–3 | C0546577 | HCG Pregnancy Test | 1383 |
7 | 26,515–7 | C0032181 | Platelet Count measurement | 1381 |
8 | 1920–8 | C0201899 | Aspartate aminotransferase measurement | 1303 |
9 | 54,363–7 | C0201913 | Bilirubin, total measurement | 1265 |
10 | 4548–4 | C0474680 | Hemoglobin A1c measurement | 1021 |
11 | 59,260–0 | C0518015 | Hemoglobin measurement | 968 |
12 | 26,511–6 | C0948762 | Absolute neutrophil count | 851 |
13 | 2164–2 | C0373595 | Creatinine clearance measurement | 758 |
14 | 15,074–8 | C0392201 | Blood glucose measurement | 633 |
15 | 69,405–9 | C3811844 | Estimated Glomerular Filtration Rate | 513 |
16 | 26,464–8 | C0023508 | White Blood Cell Count procedure | 487 |
17 | 19,197–3 | C0201544 | Prostate specific antigen measurement | 471 |
18 | 77,145–1 | C0428568 | Fasting blood glucose measurement | 400 |
19 | 5010–4 | C1533728 | Hepatitis C virus genotype determination | 352 |
20 | 72,383–3 | C5189164 | HER2 in tissue by immunoassay | 324 |
21 | 1783–0 | C0201850 | Alkaline phosphatase measurement | 287 |
22 | 14,130–9 | C3811131 | Estrogen Receptor Measurement | 283 |
23 | 10,676–5 | C1868902 | HCV viral load | 257 |
24 | 70,218–3 | C0202236 | Triglycerides measurement | 195 |
25 | 6298–4 | C0729816 | Blood potassium measurement | 194 |
26 | 34,714–6 | C0525032 | International Normalized Ratio | 191 |
27 | 40,557–1 | C0373717 | Progesterone receptor assay | 180 |
28 | 1996–8 | C0201925 | Calcium measurement | 171 |
29 | 5964–2 | C0033707 | Prothrombin time assay | 137 |
30 | 14,913–8 | C0853134 | blood testosterone measurement | 131 |
31 | 54,347–0 | C0201838 | Albumin measurement | 130 |
32 | 14,647–2 | C0201950 | Cholesterol measurement test | 130 |
33 | 22,748–8 | C0202117 | Low density lipoprotein cholesterol measurement | 126 |
34 | 69,739–1 | C0202274 | Urine drug screen | 124 |
35 | 26,446–5 | C2697913 | Leukemic Blast Count | 122 |
36 | 1986–9 | C0202100 | Insulin C-peptide measurement | 118 |
37 | 13,954–3 | C3835873 | Serum Hepatitis B E Antigen, qualitative | 113 |
38 | 3015–5 | C0202230 | Thyroid stimulating hormone measurement | 111 |
39 | 50,564–4 | C0042014 | Urinalysis | 102 |
40 | 33,763–4 | C1533071 | N terminal pro-brain natriuretic peptide level | 99 |
41 | 82,904–4 | C2074589 | chromosome studies Philadelphia | 95 |
42 | 20,570–8 | C0018935 | Hematocrit procedure | 93 |
43 | 3173–2 | C0030605 | Activated Partial Thromboplastin Time measurement | 93 |
44 | 83,098–4 | C0202022 | Follicle stimulating hormone measurement | 83 |
45 | 53,962–7 | C0201539 | Alpha one fetoprotein measurement | 80 |
46 | 10,438–0 | C3540684 | CD20 Expressing Cell Measurement | 76 |
47 | 76,485–2 | C0201657 | C-reactive protein measurement | 74 |
48 | 58,410–2 | C0009555 | Complete Blood Count | 71 |
49 | 42,595–9 | C3641250 | Hepatitis B DNA Measurement | 68 |
50 | 14,646–4 | C0428472 | Serum HDL cholesterol measurement | 63 |
51 | 20,564–1 | C0523807 | Oxygen saturation measurement | 60 |
52 | 30,395–8 | C0857490 | Granulocyte count | 58 |
53 | 29,760–6 | C0201916 | Bilirubin, direct measurement | 53 |
54 | 72,903–8 | C0005845 | Blood urea nitrogen measurement | 51 |
55 | 1992–7 | C0201924 | Calcitonin measurement | 50 |